BioNTech SE (BNTX) EBITDA Margin (2018 - 2026)
BioNTech SE's EBITDA Margin came in at -645.83% for Q2 2026, down 473.25 percentage points from -172.58% a year earlier and down 174.88 percentage points from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioNTech SE reported EBITDA Margin of -49.71%, down 29.54 percentage points year-over-year; for FY2025, it was -35.61%, up 1.33 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -26.55 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -36.94% in FY2024 (-59.82 pp), 22.88% in FY2023 (-50.87 pp), 73.75% in FY2022 (-7.19 pp) and 80.94% in FY2021 (+90.00 pp).
- The Q2 2026 figure represents the lowest quarterly EBITDA Margin since Q2 2024.
- Year-over-year, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of -27.61 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 539.38 percentage points), and the weakest in Q2 2026 (a drop of 473.25 percentage points).
- Business Quant data shows BNTX's EBITDA Margin at -470.96% (Q1 2026), -17.41% (Q4 2025) and 5.09% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | -645.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -645.83% |
| Mar 31, 2026 | -470.96% |
| Dec 31, 2025 | -17.41% |
| Sep 30, 2025 | 5.09% |
| Jun 30, 2025 | -172.58% |
| Mar 31, 2025 | -268.76% |
| Dec 31, 2024 | 26.39% |
| Sep 30, 2024 | 4.41% |
| Jun 30, 2024 | -711.97% |
| Mar 31, 2024 | -249.95% |
| Dec 31, 2023 | 40.91% |
| Sep 30, 2023 | 12.78% |
| Jun 30, 2023 | -316.88% |
| Mar 31, 2023 | 53.70% |
| Dec 31, 2022 | 77.65% |
| Sep 30, 2022 | 69.95% |
| Jun 30, 2022 | 70.16% |
| Mar 31, 2022 | 74.99% |
| Dec 31, 2021 | 85.42% |
| Sep 30, 2021 | 78.40% |
API Access
BioNTech SE EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();